Home/Filings/4/0001213900-21-020918
4//SEC Filing

Johnson Bankole A. 4

Accession 0001213900-21-020918

CIK 0001513525other

Filed

Apr 7, 8:00 PM ET

Accepted

Apr 8, 9:47 PM ET

Size

12.8 KB

Accession

0001213900-21-020918

Insider Transaction Report

Form 4
Period: 2021-04-06
Johnson Bankole A.
Director10% Owner
Transactions
  • Sale

    Common Stock

    2021-04-06$2.50/sh150,000$375,000548,336 total(indirect: By Trust)
Holdings
  • Common Stock

    (indirect: By Trust)
    93,000
  • Common Stock

    (indirect: Lina Tiouririne)
    930
  • Common Stock

    (indirect: By LLC)
    40,463
  • Common Stock

    (indirect: By Trust)
    10,000
  • Common Stock

    (indirect: Aida Tiouririne)
    930
  • Common Stock

    1,055
  • Common Stock

    (indirect: Efunbowale Johnson)
    4,650
  • Common Stock

    (indirect: By Trust)
    22,320
  • Common Stock

    (indirect: Ade Johnson)
    1,395
  • Common Stock

    (indirect: Lola Johnson)
    1,395
Footnotes (4)
  • [F1]The reporting person sold 150,000 shares of the issuer's common stock pursuant to a Stock Purchase Agreement dated as of April 6, 2021 for an aggregate purchase price of $375,000.
  • [F2]Medico-Trans Company, LLC is controlled by Bankole Johnson.
  • [F3]Dr. Johnson is the trustee of each of these trusts.
  • [F4]Dr. Johnson has a voting proxy on this person's behalf that entitles him to vote these shares.

Documents

1 file

Issuer

ADIAL PHARMACEUTICALS, INC.

CIK 0001513525

Entity typeother

Related Parties

1
  • filerCIK 0001718158

Filing Metadata

Form type
4
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 9:47 PM ET
Size
12.8 KB